Enroll in Explorica’s Travel Protection Plan Plus—$18 per tour day, maximum $270. ... or from any act or omission by bus or car rental agency, steamship, airline, railroad, taxi or tour service, hotel, ... oral statements made to me by agents of Explorica or by my school or Group Leader, applies to any Explorica tour. This
Explorica and their well-versed, experienced staff made this trip a fabulous experience. If you want a cultural, learning experience with no hassle, go with Explorica. The fact that all I had to do was leave the plane, board a bus, and arrive at my destination was phenomenal.
Educational travel tours from Explorica connect teachers and students to cultures, languages and people through authentic learning experiences.
We booked a trip through our local school#N#Covid hit, we paid for the travel insurance , trip was cancelled twice. After numerous phone calls an emails we were told we did not take out the correct insurance to protect us from cancellation.
In total we spent $3888.80 for her to go.#N#Her trip was canceled by her school board due to COVID. We were told in the beginning that if her trip was canceled through no fault of our own (the school canceling, world wide pandemic), we would be reimbursed minus the insurance expense (180.00).
Crooks. I can't believe a company is allowed to operate this way and steal kids' money during a pandemic.
We continue to proactively monitor COVID-19 with the support of our medical and risk management partners. Here are some answers to questions we're hearing from customers.
The Task Force leverages decades of experience across our company to assess the safety of the destinations we visit and help you travel with confidence in this new environment.
Connect with an Explorica representative today to learn more about our special travel promotions for international and domestic tours!
The Center for Drug Evaluation and Research (CDER) considered a clinical safety review “should focus on patients whose laboratory values deviate substantially from the reference range” in a Reviewer Guidance: Conducting a Clinical Safety Review of a New Product Application and Preparing a Report on the Review [1], since the changes in laboratory values are “much more likely to identify significant problems than mean or median change from baseline”. Reports of Potentially Clinically Significant Abnormalities (PCSA) from laboratory, Vital signs, and ECG values for selected parameters are important parts of the safety review as they provide patient information of significant deviation from normal while on treatment by treatment groups.
SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. ® indicates USA registration.
Variable ANLzzFL is to flag the “worst” value for each parameter among the post-baseline lab values in our standard ADLB programming. ANL01FL is use to select the first non-missing minimal value among all post-baseline visits, while ANL02FL is for the first non-missing maximal value, as defined in Appendix 3. ANL01FL and CRIT1FL are combined to select unique PCS-Low records for selected parameters, and ANL02FL and CRIT2FL are for unique PCS-High records. If there are more than one criterion for PCS-High, ANL03FL and CRIT3FL are for unique PCS-High records.
In ADLB, criteria variables CRIT1 and CRIT2/CRIT3 are designed to for PCS criteria related to abnormal low values and the abnormal high values. As there are a large number of laboratory parameters with PCS criteria, which may vary in each individual study, it is desirable to automatically populate those PCS criteria variables in ADLB dataset. A macro %pcsa was developed to automatically read the PCS Criteria Template datasets, generate macro variables for PCS criteria and action taken when the criteria are satisfied, and insert code into DATA step for deriving PCS criteria variables CRIT1 and CRIT2/CRIT3. The code can be shown as below: